Takepron Special Drug Use Surveillance "Gastroesophageal Reflux Disease With Dyspepsia Symptoms"

Trial Profile

Takepron Special Drug Use Surveillance "Gastroesophageal Reflux Disease With Dyspepsia Symptoms"

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Oct 2016

At a glance

  • Drugs Lansoprazole (Primary)
  • Indications Dyspepsia; Gastro-oesophageal reflux
  • Focus Therapeutic Use
  • Acronyms LEGEND
  • Sponsors Takeda
  • Most Recent Events

    • 02 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top